Aura Biosciences Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 15.8% | 14.9% | – | – | 23.5% | – | – | – | – | – | – | – | |
| – | -15.8% | -14.9% | – | – | -23.5% | – | – | – | – | – | – | – | |
| – | 986.4% | 829.4% | – | – | 1,804.0% | – | – | – | – | – | – | – | |
| – | 219.0% | 255.9% | – | – | 442.1% | – | – | – | – | – | – | – | |
| – | 1,205.4% | 1,070.4% | – | – | 2,246.1% | – | – | – | – | – | – | – | |
| – | -1,205.4% | -1,085.3% | – | – | -2,246.1% | – | – | – | – | – | – | – | |
| – | 112.2% | 112.2% | – | – | – | – | – | – | – | – | – | – | |
| – | -1,069.7% | -956.2% | – | – | -2,084.8% | – | – | – | – | – | – | – | |
| – | 6.7% | 2.2% | – | – | 1.9% | – | – | – | – | – | – | – | |
| – | -1,076.4% | -958.5% | – | – | -2,086.8% | – | – | – | – | – | – | – | |
| – | -1,054.0% | -941.3% | – | – | -2,222.6% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.